FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W36128392> ?p ?o ?g. }

• W36128392 endingPage "41" @default.
• W36128392 startingPage "1531" @default.
• W36128392 abstract "Neuroendocrine tumors of lung, including typical carcinoid (TC), atypical carcinoid (AC), large cell neuroendocrine carcinoma (LCNEC), and small cell lung carcinoma (SCLC) constitute a spectrum of malignancies in which the pathologist at times has difficulty in discerning tumor subtype and aggressiveness in a reproducible fashion. Therefore, 59 primary neuroendocrine lung tumors including 10 TCs, 26 ACs, 15 LCNECs, and 8 SCLCs were selected from cases collected from 1976 to 1988 and immunostained for p53 protein. All of these tumors were also genotyped for specific point mutational damage affecting p53 (exons 5, 7, and 8; with ACs additionally sequenced for p53 exon 6); 13 tumors for K-ras-2 (exon 1); and 31 tumors for c-raf-1 (exon 15) growth-regulatory genes. Genotyping was performed on topographically selected, minute tumor samples removed from unstained formalin-fixed, paraffin-embedded tissue sections (topographic genotyping) using polymerase chain reaction and direct sequencing. The distribution of p53 immunohistochemical staining had four patterns: negative in TCs, one-half of ACs, 3 of 15 LCNECs, and 1 of 8 SCLCs; less than 10% but more than five tumor cells per 10 high power fields (focal) in a subset (7 of 26) of aggressive ACs; 10 to 49% of tumor cells (patchy) in a subset (6 of 26) of ACs with a higher grade of aggressiveness; and 50 to 100% of tumor cells (diffuse), exclusively seen in LCNECs (12 of 15) and SCLCs (7 of 8). Three patterns of immunohistochemical staining intensity of p53 protein were seen: negative, weak or mild, and moderate to marked. SCLCs and LCNECs accounted for cases of moderate to marked staining and were the only ones to have mutations in p53 exons 5, 7, or 8. No mutations were found in AC and TC, showing absent to weak staining and no staining, respectively. The difference in distribution and staining intensities between LCNEC and SCLC compared with AC and TC was statistically significant (P < 0.001). Patients having AC with patchy p53 immunostaining usually had survival limited to 3 years, whereas those having AC with focal p53 immunostaining subsequently developed metastatic or recurrence of AC disease (P < 0.05). The absence of point mutations in cases with patchy or focal immunostaining suggests increased expression of wild-type p53 tumor suppressor protein likely in response to growth deregulation in a more aggressive subtype of AC. A novel hypothesis is presented in regard to these findings. K-ras-2 and c-raf-1 gene sequence analysis showed no evidence of point mutational change in any of the tumors studied. The TC and AC categories are therefore genetically distinct from the higher grade neuroendocrine SCLC and LCNEC. Immunohistochemistry for p53 on AC lung tumors may be helpful to delineate cases at higher risk for aggressive behavior. Additionally, although LCNEC is categorized as a non-small-cell carcinoma, it is more akin genetically and immunohistochemically to SCLC." @default.
• W36128392 created "2016-06-24" @default.
• W36128392 creator A5016222783 @default.
• W36128392 creator A5026778511 @default.
• W36128392 creator A5040537346 @default.
• W36128392 creator A5044483075 @default.
• W36128392 creator A5048271358 @default.
• W36128392 creator A5061124879 @default.
• W36128392 creator A5085005018 @default.
• W36128392 creator A5088478187 @default.
• W36128392 creator A5088564762 @default.
• W36128392 date "1996-05-01" @default.
• W36128392 modified "2023-09-27" @default.
• W36128392 title "Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome." @default.
• W36128392 cites W1496493476 @default.
• W36128392 cites W1501970115 @default.
• W36128392 cites W1506367280 @default.
• W36128392 cites W1513820318 @default.
• W36128392 cites W1596485672 @default.
• W36128392 cites W1608841109 @default.
• W36128392 cites W1965173366 @default.
• W36128392 cites W1968351606 @default.
• W36128392 cites W1969853551 @default.
• W36128392 cites W1982891395 @default.
• W36128392 cites W1989205333 @default.
• W36128392 cites W2002469904 @default.
• W36128392 cites W2002873037 @default.
• W36128392 cites W2009408491 @default.
• W36128392 cites W2012053348 @default.
• W36128392 cites W2019187279 @default.
• W36128392 cites W2034181664 @default.
• W36128392 cites W2042316019 @default.
• W36128392 cites W2065766428 @default.
• W36128392 cites W2071405980 @default.
• W36128392 cites W2081024021 @default.
• W36128392 cites W2081472137 @default.
• W36128392 cites W2082880507 @default.
• W36128392 cites W2085172497 @default.
• W36128392 cites W2089316398 @default.
• W36128392 cites W2091392373 @default.
• W36128392 cites W2091890751 @default.
• W36128392 cites W2091909828 @default.
• W36128392 cites W2091976105 @default.
• W36128392 cites W2099907467 @default.
• W36128392 cites W2111308370 @default.
• W36128392 cites W2133891200 @default.
• W36128392 cites W2152205227 @default.
• W36128392 cites W2170188255 @default.
• W36128392 cites W2301471934 @default.
• W36128392 cites W2318856916 @default.
• W36128392 cites W2320138981 @default.
• W36128392 cites W2342173893 @default.
• W36128392 cites W2344007777 @default.
• W36128392 cites W2396252519 @default.
• W36128392 cites W2411307169 @default.
• W36128392 cites W2416711677 @default.
• W36128392 cites W2417120197 @default.
• W36128392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1861560" @default.
• W36128392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8623922" @default.
• W36128392 hasPublicationYear "1996" @default.
• W36128392 type Work @default.
• W36128392 sameAs 36128392 @default.
• W36128392 citedByCount "52" @default.
• W36128392 countsByYear W361283922012 @default.
• W36128392 countsByYear W361283922013 @default.
• W36128392 countsByYear W361283922014 @default.
• W36128392 countsByYear W361283922015 @default.
• W36128392 countsByYear W361283922016 @default.
• W36128392 countsByYear W361283922017 @default.
• W36128392 countsByYear W361283922019 @default.
• W36128392 countsByYear W361283922021 @default.
• W36128392 crossrefType "journal-article" @default.
• W36128392 hasAuthorship W36128392A5016222783 @default.
• W36128392 hasAuthorship W36128392A5026778511 @default.
• W36128392 hasAuthorship W36128392A5040537346 @default.
• W36128392 hasAuthorship W36128392A5044483075 @default.
• W36128392 hasAuthorship W36128392A5048271358 @default.
• W36128392 hasAuthorship W36128392A5061124879 @default.
• W36128392 hasAuthorship W36128392A5085005018 @default.
• W36128392 hasAuthorship W36128392A5088478187 @default.
• W36128392 hasAuthorship W36128392A5088564762 @default.
• W36128392 hasConcept C104317684 @default.
• W36128392 hasConcept C126322002 @default.
• W36128392 hasConcept C135763542 @default.
• W36128392 hasConcept C142724271 @default.
• W36128392 hasConcept C204232928 @default.
• W36128392 hasConcept C2777546739 @default.
• W36128392 hasConcept C2777714996 @default.
• W36128392 hasConcept C2779066768 @default.
• W36128392 hasConcept C2779292878 @default.
• W36128392 hasConcept C2909444961 @default.
• W36128392 hasConcept C31467283 @default.
• W36128392 hasConcept C36823959 @default.
• W36128392 hasConcept C54355233 @default.
• W36128392 hasConcept C71924100 @default.
• W36128392 hasConcept C74864618 @default.
• W36128392 hasConcept C86803240 @default.
• W36128392 hasConceptScore W36128392C104317684 @default.

• next